Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-5334 in Postmenopausal Women With Osteopenia or Osteoporosis
2007-002417-39Phase 2Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ONO-5334 in osteoporosis and osteopenia (3 arms), sponsored by Ono Pharmaceutical. Started Jul 2007; status: completed.
02
Drugs
ONO-5334
03
Conditions
osteoporosisosteopenia
Beyond the preview
Go deeper on 2007-002417-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002417-39.